Guggenheim Capital’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-16,349
| Closed | -$64K | – | 2797 |
|
|
2018
Q1 | $64K | Buy |
16,349
+4,499
| +38% | +$17.6K | ﹤0.01% | 2692 |
|
|
2017
Q4 | $32K | Sell |
11,850
-1,480
| -11% | -$4K | ﹤0.01% | 2655 |
|
|
2017
Q3 | $43K | Buy |
+13,330
| New | +$43K | ﹤0.01% | 2708 |
|
|
2017
Q1 | – | Sell |
-6,302
| Closed | -$25K | – | 3008 |
|
|
2016
Q4 | $25K | Hold |
6,302
| – | – | ﹤0.01% | 2835 |
|
|
2016
Q3 | $24K | Sell |
6,302
-57
| -0.9% | -$217 | ﹤0.01% | 2813 |
|
|
2016
Q2 | $22K | Sell |
6,359
-456
| -7% | -$1.58K | ﹤0.01% | 2806 |
|
|
2016
Q1 | $36K | Buy |
6,815
+2,045
| +43% | +$10.8K | ﹤0.01% | 2802 |
|
|
2015
Q4 | $59K | Buy |
4,770
+734
| +18% | +$9.08K | ﹤0.01% | 2886 |
|
|
2015
Q3 | $59K | Sell |
4,036
-192
| -5% | -$2.81K | ﹤0.01% | 2840 |
|
|
2015
Q2 | $83K | Buy |
4,228
+178
| +4% | +$3.49K | ﹤0.01% | 2915 |
|
|
2015
Q1 | $73K | Buy |
4,050
+838
| +26% | +$15.1K | ﹤0.01% | 2890 |
|
|
2014
Q4 | $76K | Buy |
3,212
+474
| +17% | +$11.2K | ﹤0.01% | 2868 |
|
|
2014
Q3 | $67K | Sell |
2,738
-4,081
| -60% | -$99.9K | ﹤0.01% | 2867 |
|
|
2014
Q2 | $192K | Sell |
6,819
-986
| -13% | -$27.8K | ﹤0.01% | 2871 |
|
|
2014
Q1 | $266K | Buy |
7,805
+1,334
| +21% | +$45.5K | ﹤0.01% | 2730 |
|
|
2013
Q4 | $124K | Buy |
6,471
+254
| +4% | +$4.87K | ﹤0.01% | 2881 |
|
|
2013
Q3 | $102K | Buy |
6,217
+814
| +15% | +$13.4K | ﹤0.01% | 2791 |
|
|
2013
Q2 | $57K | Buy |
+5,403
| New | +$57K | ﹤0.01% | 2814 |
|